Neuberg Diagnostics Secures INR 940 Cr from Kotak Alt

This marks the largest primary fund-raise in the Indian diagnostics sector, positioning the company for strategic expansion and advancements in healthcare delivery.

Neuberg Diagnostics, a leading diagnostics provider in India, has raised INR 940 Cr in funding from Kotak Alt. 

This marks the largest primary fund-raise in the Indian diagnostics sector, positioning the company for strategic expansion and advancements in healthcare delivery.

Dr GSK Velu, Founder and Managing Director of Neuberg Diagnostics, said, “This funding will enable us to enhance our capabilities in the areas of personalized medicine, integrated diagnostics, and inorganically expand our footprint across the country.”

Established in 2017 and headquartered in Chennai, Neuberg Diagnostics has quickly grown into one of India’s largest integrated diagnostics players. The company’s infrastructure includes over 250 laboratories and a network of more than 10,000 touchpoints spread across 250 cities. 

It is equipped to conduct over 5,000 tests, facilitated by a skilled team of clinical pathologists, oncopathologists, biochemists, geneticists, and certified laboratory professionals.

Rahul Shah, Partner at Kotak Alt, commented on the partnership, “We are confident that this strategic investment will play a key role in increasing the scale of Neuberg Diagnostics and helping the company prepare for its upcoming IPO.”

The financial advisory for this fund-raising was managed by o3 Capital, acting as the exclusive advisor to Neuberg Diagnostics.